We also reported that activin treatment of CRC cells increased pAKT activation in the absence of SMAD4 in vitro [8]; therefore, we aimed to test the effect of activin-induced PI3K/AKT activity in CRC in vivo. The gene discussed is AKT1; the disease is colorectal carcinoma.